About the Company
syros pharmaceuticals is a life sciences company that is focused on treating disease by mapping gene regulatory circuits and modulating the factors that regulate gene expression. syros has pioneered world-leading gene control research and drug discovery capabilities with a proven ability to integrate disease biology and genomic data--a proficiency that is not well represented in pharmaceutical r&d. central to the syros approach is a proprietary platform of carefully integrated assay technologies, bioinformatics, and biologic insights developed by members of syros' senior leadership. while this scientific approach has applications in many therapeutic areas, syros has demonstrated success initially in oncology, where it may help address numerous unmet medical needs.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $SYRS News
Syros Pharmaceuticals Inc.
SYROS PHARMACEUTICALS INC's gross profit margin for the third quarter of its fiscal year 2023 has significantly increased when compared to the same period a year ago. Sales and net income have ...
Syros (SYRS) Stock Surges 200% in 3 Months: Here's Why
Syros Pharmaceuticals, Inc. SYRS shares have skyrocketed 200% in the past three months compared with the industry’s rise of 13.1%. This clinical-stage company is developing its pipeline ...
Syros Pharmaceuticals, Inc. (0LC7.L)
*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
Syros Pharmaceuticals, Inc. (0S90.F)
*Close price adjusted for splits.**Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
Syros Pharmaceuticals Inc SYRS
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Syros Pharmaceuticals Inc SYRS
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Syros Pharmaceuticals, Inc. Common Stock (SYRS)
Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...
Syros Pharmaceuticals, Inc. (SYRS)
*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
Syros Pharmaceuticals Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Syros Pharmaceuticals Inc (SYRS)
Syros Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing new standards of care for the frontline treatment of patients with hematologic malignancies. Its lead ...
Loading the latest forecasts...